Full View

Targeted suppression of miRNA-33 using pHLIP improves atherosclerosis regression

X Zhang, N Rotllan, A Canfrán-Duque, J Sun… - Circulation …, 2022 - Am Heart Assoc
Background: miRNA therapeutics have gained attention during the past decade. These
oligonucleotide treatments can modulate the expression of miRNAs in vivo and could be …
被引用次数：32 相关文章

Targeted Suppression of miRNA-33 Using pHLIP Improves Atherosclerosis Regression

X Zhang, N Rotllan, A Canfrán-Duque… - Circulation …, 2022 - ingentaconnect.com
Background: miRNA therapeutics have gained attention during the past decade. These
oligonucleotide treatments can modulate the expression of miRNAs in vivo and could be …

Targeted Suppression of miRNA-33 Using pHLIP Improves Atherosclerosis Regression.

X Zhang, N Rotllan, A Canfrán-Duque, J Sun… - Circulation …, 2022 - europepmc.org
Background miRNA therapeutics have gained attention during the past decade. These
oligonucleotide treatments can modulate the expression of miRNAs in vivo and could be …

Targeted Suppression of miRNA-33 Using pHLIP Improves Atherosclerosis Regression

X Zhang, N Rotllan, A Canfrán-Duque, J Sun… - Circulation …, 2022 - Am Heart Assoc
BACKGROUND: miRNA therapeutics have gained attention during the past decade. These
oligonucleotide treatments can modulate the expression of miRNAs in vivo and could be …
[PDF] researchgate.net

[PDF][PDF] Targeted Suppression of miRNA-33 Using pHLIP Improves Atherosclerosis Regression

X Zhang, N Rotllan, A Canfrán-Duque, J Sun… - Circulation …, 2022 - researchgate.net
BACKGROUND: miRNA therapeutics have gained attention during the past decade. These
oligonucleotide treatments can modulate the expression of miRNAs in vivo and could be …

Targeted Suppression of miRNA-33 Using pHLIP Improves Atherosclerosis Regression

X Zhang, N Rotllan, A Canfrán-Duque… - Circulation …, 2022 - pubmed.ncbi.nlm.nih.gov
Background miRNA therapeutics have gained attention during the past decade. These
oligonucleotide treatments can modulate the expression of miRNAs in vivo and could be …

[引用][C] Targeted Suppression of miRNA-33 Using pHLIP Improves Atherosclerosis Regression

X Zhang, N Rotllan, A Canfrán-Duque, J Sun… - CIRCULATION …, 2022 - air.unipr.it
Targeted Suppression of miRNA-33 Using pHLIP Improves Atherosclerosis Regression IRIS IRIS
Home Sfoglia Macrotipologie & tipologie Autore Titolo Riviste Serie IT Italiano Italiano English …
[HTML] nih.gov

[HTML][HTML] Targeted Suppression of miRNA-33 Using pHLIP Improves Atherosclerosis Regression

X Zhang, N Rotllan, A Canfrán-Duque, J Sun… - Circulation …, 2022 - ncbi.nlm.nih.gov
Background: miRNA therapeutics have gained attention during the past decade. These
oligonucleotide treatments can modulate the expression of miRNAs in vivo and could be …